| Filed On | Filing |
|---|---|
| 08 Aug 2022 |
8-K/A: Costs Associated with Exit or Disposal Activities
On June 2, 2022, ANI Pharmaceuticals, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Prior 8-K”) announcing its decision to cease operations at its manufacturing plant located in Oakville, Ontario, Canada as part of ongoin... |
| 16 Aug 2016 |
8-K/A: Regulation FD Disclosure
A Specialty Pharmaceutical Company NASDAQ: ANIP GENERIC AND BRANDED PRESCRIPTION DRUG PRODUCTS Corporate Presentation August 2016 |
| 27 Oct 2014 |
8-K/A: Results of Operations and Financial Condition
BAUDETTE, Minnesota (October 27, 2014) – ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its third quarter and year-to-date 2014 financial results on Monday, November 3, 2014, before the opening... |
| 27 Jun 2013 |
8-K/A: Financial Statements and Exhibits
We have audited the accompanying balance sheet of ANIP Acquisition Company (d/b/a ANI Pharmaceuticals, Inc.) (the “Company”) as of December 31, 2012, and the related statements of operations, changes in redeemable convertible preferred s... |
| 07 Jun 2010 |
8-K/A: Other Events
[Portions of this Exhibit have been omitted pursuant to a request for confidentiality under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. The confidential portions of this Exhibit that have been omitted are marked with “... |
| 19 Sep 2003 |
8-K/A: Other Events
On August 6, 2003, BioSante Pharmaceuticals, Inc. issued a press release, a copy of which is attached hereto, announcing the completion of a private placement of an aggregate of 4,791,982 shares of its common stock and warrants to purcha... |
Loading...